Abstract

Background and Objectives: Serum Calcium and serum potassium are two important elements in regulating cardiovascular functions. Alteration in these have been shown to be associated with hypertension. Serum calcium levels are found to be significantly reduced in hypertension, however serum potassium levels have been found to be variable in hypertensive patients. Methods: This study was conducted in tertiary care hospital which is a case control study in which newly detected patients with essential hypertension are enrolled. Serum calcium and serum potassium were estimated in all the patients at the time of study. Serum potassium levels were correlated with age, gender, grades of hypertension and ECG changes. Results: A total of 75 patients were studied, 50 were cases and 25 controls. majority were in the age group of 46 to 55 years , mean ages among the cases and controls were 49.52±4.67 years and 51.80±9.61 years respectively .Mean systolic (SBP) among the cases and controls were 165.40±10.93 mm Hg and 127.92±10.01 mm Hg and the mean diastolic blood pressures (DBP) were 96.80±7.13 mm Hg and 77.04±5.29 mm Hg respectively .serum calcium levels were significantly lesser among the cases of hypertension (8.05±0.41 mg/dL) compared to controls (8.68±0.34 mg/dL) who did not have hypertension (P<0.05). Serum potassium levels did not vary among the cases (4.51±0.42 mmol/L) and controls (4.64±0.48 mmol/L) (P>0.05). Corrected serum calcium levels were decreased in patients with newly detected hypertension compared with controls. However serum potassium level did not show any difference between cases and controls. Significant negative correlation was found between corrected serum calcium levels and systolic and diastolic blood pressure. Conclusion: Corrected serum calcium levels were reduced in patients with essential hypertension and significant negative correlation was seen between corrected serum calcium levels and systolic and diastolic blood pressures but no correlation was found with serum potassium levels.

References

1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. The lancet. 2005 Jan 15;365(9455):217-23.
2. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL, Jones DW, Materson BJ, Oparil S, Wright Jr JT, Roccella EJ. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. hypertension. 2003 Dec 1;42(6):1206-52.
3. Carretero OA, Oparil S. Essential hypertension: part I: definition and etiology. Circulation. 2000 Jan 25;101(3):329-35.
4. World Health Organization. The world health report 2002: reducing risks, promoting healthy life. World Health Organization; 2002.
5. Zidek W, Vetter H, Dorst KG, Zumkley H, Losse H. Intracellular Na+ and Ca2+ activities in essential hypertension.
6. Aviv A. The links between cellular Ca2+ and Na+/H+ exchange in the pathophysiology of essential hypertension. American journal of hypertension. 1996 Jul 1;9(7):703-7.
7. Jha K, Kumari P. Serum Calcium in Essential Hypertension and its Co-relation with Severity of the Disease. Advanced Studies in Biology. 2011;3(7):319-25.
8. Kaplan NM, Gifford RW. Choice of initial therapy for hypertension. Jama. 1996 May 22;275(20):1577-80.
9. Ranjani G. Estimation of serum calcium and serum phosphorus levels in newly detected essential hypertensive patients.
10. Bijlani RL, Manjunatha S. Understanding medical physiology: a textbook for medical students. Jaypee Brothers Publishers; 2010 Nov 26.
11. Uday. S. Bande, Prashanth Huballi; study of serum calcium in essential hypertension-ejpmr,2016,3(6),516-525.
12. Touyz RM, Milne FJ. Alterations in intracellular cations and cell membrane ATPase activity in patients with malignant hypertension. Journal of hypertension. 1995 Aug;13(8):867-74.
13. Fu Y, Wang S, Lu Z, Li H, Li S. Erythrocyte and plasma Ca2+, Mg2+ and cell membrane adenosine triphosphatase activity in patients with essential hypertension. Chinese medical journal. 1998 Feb;111(2):147-9.
14. Midtbø K, Hals O. Serum Ionized Calcium A Predictor of Therapeutic Response to Slow Calcium Channel Blockade in Essential Hypertension. Angiology. 1987 Nov;38(11):841-6.
15. Martinez C. Calcium and hypertension. Nutrition bytes. 1998 Jan 1;4(2).
16. Prabhakaran R, Hussaini SB, Vrinda V, Kalil A. A Study of Serum Total Calcium and Serum Calcium/Phosphorus Ratio in Essential Hypertension and Its Correlation with Severity of the Disease. Indian Journal of Applied Research. 2018 Oct 10;7(5).
17. August P, Suthanthiran M. Transforming growth factor signaling, vascular remodeling, and hypertension. N Engl J Med. 2006;354:2721-3.
18. Sudhakar K, Sujatha M, Babu SR, Padmavathi P, Reddy PP. Serum calcium levels in patients with essential hypertension and their first-degree relatives. Indian Journal of Clinical Biochemistry. 2004 Jan 1;19(1):21-3.
19. Lohmeier TE, Irwin ED, Rossing MA, Serdar DJ, Kieval RS. Prolonged activation of the baroreflex produces sustained hypotension. Hypertension. 2004 Feb 1;43(2):306-11.
20. Anil S Mane. Correlation between serum sodium and potassium levels and risk of developing hypertension. International Journal of Contemporary Medical Research 2018;5(11):K5-K9.
21. Walsh CR, Larson MG, Vasan RS, et al. Serum potassium is not associated with blood pressure tracking in the Framingham Heart Study. Am J Hypertens 2002; 15: 130–136.